ASSESSMENT OF NANOBIOTECHNOLOGY-TARGETED SIRNA DESIGNED TO INHIBIT NF-KAPPAB CLASSICAL AND ALTERNATIVE SIGNALING IN BREAST TUMOR MACROPHAGES

Vanderbilt University, The

Investigators